Data from the RestorAATion-2 clinical trial of WVE-006 (GalNAc-RNA editing), including new data from the 400 mg multidose ...

Q4 2025 earnings call recap: 60% revenue growth, 2026 guidance of $60–$62M, PEDD/TriNav expansion, funding and risks—read now.

The project is part of the up to $30 million investment in biomanufacturing workforce development launched in September 2025. The city of New Albany pledged an additional $5 million to the project ...

Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...

Venture capital firm Portal Innovations is planning to open a 30,000-square-foot science incubator in Salt Lake City while ...

Merck KGaA (ETR:MRK) executives told investors the company delivered “solid” organic growth in 2025 despite a challenging ...

BNY Mellon Small/Mid Cap Growth Fund (Class A shares at NAV) outperformed its benchmark, the Russell 2500 Growth Index, during the fourth quarter of 2025.

Two Melbourne entrepreneurs have raised money from members of the Myer family, with their biotech now valued at $90 million.

How do biological cells join forces to form a structure? In her Ph.D. research, Daphne Nesenberend uses mathematics to show ...

After delivering solid sales growth in a difficult 2025, Germany’s Merck KGaA may have a tougher go of things this year, which the company is crediting in part to a predicted onslaught of U.S.

Germany’s Merck KGaA reported broadly stable full-year 2025 results, with modest top-line pressure from currency headwinds ...

At least five schools in Columbus were targeted by threats on Wednesday.